SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 231 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $810,057 | -38.5% | 914,286 | +8.9% | 0.01% | -28.6% |
| Q3 2022 | $1,318,000 | -20.9% | 839,744 | +1.3% | 0.01% | -30.0% |
| Q2 2022 | $1,666,000 | +202.4% | 829,079 | +250.7% | 0.01% | +100.0% |
| Q1 2022 | $551,000 | +634.7% | 236,400 | +1360.1% | 0.01% | +400.0% |
| Q4 2021 | $75,000 | -63.2% | 16,191 | -23.0% | 0.00% | -50.0% |
| Q2 2021 | $204,000 | -35.4% | 21,028 | -25.8% | 0.00% | -60.0% |
| Q3 2020 | $316,000 | -84.5% | 28,335 | -91.3% | 0.01% | -85.7% |
| Q2 2020 | $2,038,000 | +1007.6% | 324,600 | +3012.2% | 0.04% | +288.9% |
| Q2 2015 | $184,000 | -9.8% | 10,430 | -40.8% | 0.01% | -10.0% |
| Q1 2015 | $204,000 | – | 17,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |